Anticoagulation in hospitalized patients with COVID-19-Reference-Cited by-同舟云学术

Anticoagulation in hospitalized patients with COVID-19

Published:2022-08-25 Issue:8 Volume:140 Page:809-814
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Baumann Kreuziger Lisa¹^ORCID,Sholzberg Michelle²³^ORCID,Cushman Mary⁴⁵^ORCID

Affiliation:

1. 1Department of Medicine Medical College of Wisconsin, Blood Research Institute, Versiti, Milwaukee, WI;

2. 2Department of Medicine and

3. 3Department of Laboratory Medicine and Pathobiology, St. Michael’s Hospital, Li Ka Shing Knowledge Institute, University of Toronto, Toronto, ON, Canada; and

4. 4Department of Medicine and

5. 5Department of Pathology & Laboratory Medicine, Larner College of Medicine, University of Vermont, Burlington, VT

Abstract

Abstract Coronavirus disease-19 (COVID-19) includes a thromboinflammatory syndrome that may manifest with microvascular and macrovascular thrombosis. Patients with COVID-19 have a higher incidence of venous thromboembolism than other hospitalized patients. Three randomized control trials suggesting benefit of therapeutic heparin in hospitalized noncritically ill patients with COVID-19 have led to conditional guideline recommendations for this treatment. By contrast, prophylactic-dose heparin is recommended for critically ill patients. Unprecedented collaboration and rapidly funded research have improved care of hospitalized patients with COVID-19.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

https://ashpublications.org/blood/article-pdf/140/8/809/1916670/bloodbld2021014527c.pdf

Reference42 articles.

1. American Society of Hematology 2018 guidelines for management of venous thromboembolism: prophylaxis for hospitalized and nonhospitalized medical patients;Schünemann;Blood Adv.,2018

2. Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia;Cui;J Thromb Haemost.,2020

3. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection;Al-Samkari;Blood.,2020

Cited by 18 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Extracorporeal membrane oxygenation aggravates platelet glycoprotein V shedding and δ-granule deficiency in COVID-19–associated acute respiratory distress syndrome;Journal of Thrombosis and Haemostasis;2024-08

2. Prevalence, Predictors, and Outcomes of Type 2 NSTEMI in Hospitalized Patients With COVID‐19;Journal of the American Heart Association;2024-05-21

3. Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials;International Journal of Surgery;2024-03-28

4. Sars-CoV-2 infection in different hematological patients;Management, Body Systems, and Case Studies in COVID-19;2024

5. Low-molecular-weight heparin for the prevention of clinical worsening in severe non-critically ill COVID-19 patients: a joint analysis of two randomized controlled trials;Internal and Emergency Medicine;2023-10-04